Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies. | Adv Ther (Weinh) | 2022 | 36211621 | PubTator, text mining | PubMed |
| Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander? | Front Immunol | 2022 | 36211440 | PubTator, text mining | PubMed |
| Genetic analysis of CFH and MCP in Egyptian patients with immune-complex proliferative glomerulonephritis. | Front Immunol | 2022 | 36211394 | PubTator, text mining | PubMed |
| Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods. | Front Immunol | 2022 | 36203586 | PubTator, text mining | PubMed |
| Phagocytosing differentiated cell-fragments is a novel mechanism for controlling somatic stem cell differentiation within a short time frame. | Cell Mol Life Sci | 2022 | 36203068 | PubTator, text mining | PubMed |
| Age-related macular degeneration and myeloproliferative neoplasms - A common pathway. | Acta Ophthalmol | 2022 | 36200281 | PubTator, text mining | PubMed |
| Innate and adaptive immune evasion by dengue virus. | Front Cell Infect Microbiol | 2022 | 36189361 | PubTator, text mining | PubMed |
| The role of the complement system in kidney glomerular capillary thrombosis. | Front Immunol | 2022 | 36189215 | PubTator, text mining | PubMed |
| Nonsynonymous amino acid changes in the α-chain of complement component 5 influence longitudinal susceptibility to Plasmodium falciparum infections and severe malarial anemia in kenyan children. | Front Genet | 2022 | 36186473 | PubTator, text mining | PubMed |
| Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s. | J Biol Chem | 2022 | 36183830 | PubTator, text mining | PubMed |
| The complement system and autoimmune diseases. | Chronic Dis Transl Med | 2022 | 36161202 | PubTator, text mining | PubMed |
| Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities. | Front Cardiovasc Med | 2022 | 36158829 | PubTator, text mining | PubMed |
| Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review. | World J Exp Med | 2022 | 36157337 | PubTator, text mining | PubMed |
| ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers. | BMC Biol | 2022 | 36153585 | PubTator, text mining | PubMed |
| Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles. | J Control Release | 2022 | 36152807 | PubTator, text mining | PubMed |
| The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer. | Int J Mol Sci | 2022 | 36142489 | PubTator, text mining | PubMed |
| Rational Approach to Finding Genes Encoding Molecular Biomarkers: Focus on Breast Cancer. | Genes (Basel) | 2022 | 36140706 | PubTator, text mining | PubMed |
| Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Impairs Bradykinin-Induced Relaxation in Neonatal Porcine Coronary Arteries. | Biomedicines | 2022 | 36140183 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors. | Nat Commun | 2022 | 36127336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=31